Presentations
The attorneys of BSKB regularly present lecture on an array of intellectual property topics.
-
March 8, 2023
Duty of Disclosure and Duty of Reasonable Inquiry
-
February 22, 2023
Pushing Back against Obviousness Rejections Unsupported by Evidence and Lacking Reasoned Explanations: A discussion of In re Google LLC.
-
February 8, 2023
LKQ CORP, KEYSTONE V. GM GLOBAL No. 2021-2348 (Fed. Cir. 2023)
-
November 16, 2022
Overview of AI Application and Related Issues
-
November 2, 2022
Biogen International GmbH et al. v. Mylan Pharmaceuticals Inc.: Another hurdle for Pharmaceutical Patents
-
October 12, 2022
Setting Sail for Safe Harbor: Is the use of “research tools” eligible for Safe Harbor protection under 35 U.S.C. § 271(e)(1)?
-
September 14, 2022
YouTube and Copyright: How YouTube and Copyright Owners Manage Copyrights? What are the rights of YouTubers?
-
May 11, 2022
Discussion of Inter Partes Review and a Patent Owner's Motion to Amend to Add Substitute Claims
-
April 27, 2022
'Code' and 'Application' Limitations Found to Connote Sufficient Structure to Avoid Means-Plus-Function Interpretation: A Discussion of Dyfan, LLC v. Target Corp.
-
April 20, 2022
Enforcing A Medical Device Patent – Definiteness And Induced Infringement
-
March 30, 2022
Recent Court Decisions
-
March 9, 2022
Range Limitations in Patent Claims
-
January 26, 2022
Patent Eligibility of User Authentication: A Review of CosmoKey Solutions v. Duo Security
-
October 27, 2021
More Constitutional Troubles for the Patent Trial and Appeal Board: A Review of Mobility Workx v. Unified Patents
-
October 6, 2021
Formula One Racing and Intellectual Property - Do Auto Racing and IP Mix?
-
September 15, 2021
Juno Therapeutics, INC., Sloan Kettering Institute for Cancer Research v. Kite Pharma, INC.
-
June 9, 2021
Raytheon Technologies Corporation v. General Electric Company (Fed. Cir. 2021)
-
May 26, 2021
Trimble Inc., Innovative Software Engineering, LLC, v. PerDiemCo LLC Case
-
April 21, 2021
A Review of USPTO Pilot Programs and Initiatives
-
April 7, 2021
IBSA Institut Biochimique, S.A. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2020)